Pharmaids Pharmaceuticals Ltd

Pharmaids Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Pharmaids Pharmaceuticals Ltd

₹ 49.7 0.18%
22 Jul - close price
pharmaids.com BSE: 524572
About

Incorporated in 1989, Pharmaids Pharmaceuticals Ltd manufactures Bulk Drugs and Intermediaries.

Key Points

Product Portfolio:
a) Specialty Chemicals:[1] Retinol, DL Alpha Tocopherol, D-Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10, D-Biotin
b) Skin Care:[2] Best care hands, Hands Sanitizer, Moisturizing Cream, Skin-Sure Plus, Skin-Sure Ultra, Alcohol Gel, Barrier Cream
c) Hospital Care:[3] Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen-G, Strumen TRIACID, Facein Eco, Facein Power, Facein Spray, Sod Hypochlorite, Wipes, PPE
d) Generics:[4] Linzomust, Ceforoot 1.5g, Trendyclav-L, Cobasure Gold 2ML INJ, Benfoshine, Amplimmune, Thiaxa T8, Molprime SR, Citibrain-Plus, Duojoint

Website BSE
  • Market Cap ₹ 175 Cr.
  • Current Price ₹ 49.7
  • High / Low ₹ 79.2 / 31.8
  • Stock P/E
  • Book Value ₹ 20.4
  • Dividend Yield 0.00 %
  • ROCE -27.8 %
  • ROE -16.9 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 94.4 to 64.7 days.

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 5.56%
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -60.2%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
0.00 0.00 0.00 0.00 0.00 0.02 5.81
0.54 0.69 8.60 1.61 1.02 2.45 11.39
Operating Profit -0.54 -0.69 -8.60 -1.61 -1.02 -2.43 -5.58
OPM % -12,150.00% -96.04%
0.00 0.00 0.00 0.41 -0.26 0.76 0.12
Interest 0.00 0.00 0.00 0.00 0.00 0.02 0.77
Depreciation 0.01 0.01 0.00 0.01 0.01 0.04 0.63
Profit before tax -0.55 -0.70 -8.60 -1.21 -1.29 -1.73 -6.86
Tax % 0.00% 0.00% -28.37% 7.44% -60.47% -33.53% -7.73%
-0.55 -0.71 -6.16 -1.30 -0.50 -1.15 -6.33
EPS in Rs -0.53 -0.54 -2.87 -0.61 -0.23 -0.54 -1.57
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
4 0 15
4 10 28
Operating Profit 0 -10 -13
OPM % 3% -87%
0 0 1
Interest 0 0 2
Depreciation 0 0 2
Profit before tax 0 -10 -16
Tax % 0% -24% -24%
0 -8 -12
EPS in Rs 0.15 -3.52 -2.26
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -5%
Stock Price CAGR
10 Years: 29%
5 Years: 59%
3 Years: 41%
1 Year: 12%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Equity Capital 10 21 35
Reserves -2 1 37
0 0 9
2 2 11
Total Liabilities 11 25 91
0 0 63
CWIP 0 2 7
Investments 0 3 0
11 19 21
Total Assets 11 25 91

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
-0 -4 -11
0 -5 -75
0 21 78
Net Cash Flow 0 12 -8

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 124 65
Inventory Days 91 0 114
Days Payable 236 163
Cash Conversion Cycle -21 16
Working Capital Days -18 -9
ROCE % -64% -28%

Shareholding Pattern

Numbers in percentages

3 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
65.65% 55.56% 35.44% 20.70% 21.08% 16.54% 9.95% 9.94% 9.70% 9.25% 5.64% 5.56%
34.35% 44.44% 64.56% 79.30% 78.92% 83.47% 90.05% 90.07% 90.31% 90.75% 94.36% 94.44%
No. of Shareholders 7,3318,3149,6209,4959,1938,1967,7617,4767,3937,2817,5677,594

Documents

Announcements

Annual reports